1st medical device approved for the treatment of fibromyalgia
September 13, 2024
Remedee Labs, a French start-up that specializes in non-pharmacological treatments for chronic pain has obtained medical device status in Europe
Remedee Labs, a French start-up that specializes in non-pharmacological treatments for chronic pain has obtained medical device status in Europe
Remedee Labs, a French startup that specializes in non-pharmaceutical treatments for chronic pain, is announcing the highly anticipated results of
Remedee Labs, a French start-up that specializes in non-pharmaceutical chronic pain management and just announced the positive results of its
February 1st, 2023 – Today, the French pharmaceutical company UPSA and the startup Remedee Labs are announcing the signature of a
Remedee Labs, a French start-up that specializes in non-pharmaceutical treatments for chronic pain, is announcing a new €12.2 million funding
Remedee Labs, a Grenoble-based startup specializing in integrated chronic pain care centered on its unique endorphin stimulation technology, is joining
On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough
French health tech startup Remedee Labs, designer of the first endorphin stimulator for personal use, is hiring Gilles Litman to
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Their mission
The challenge of measuring endorphin levels The analgesic effect of millimeter wave (MMW) therapy is due to the release of